The U.S. IVF market was valued at $4,905.46 million in 2020, and is expected to reach $5,563.06 million by 2027, registering a CAGR of 6.8% from 2019 to 2027. IVF is a complex series of procedure used to help by fertility or avoid genetic problems and assist with the conception of a child. Throughout IVF, mature eggs are collected from ovaries and fertilized by sperm in a lab The U.S. IVF market experiences growth, owing to rise in number of infertility cases, availability of skilled professionals, and technological advancements including preimplantation genetic diagnosis (PGD) and three-parent IVF procedures.
Delayed pregnancies; aging of women population, which lowers conception rates; and introduction of new & advanced products of IVF treatments enhance market growth. IVF procedures are associated with high success rate, thus fueling market growth. For instance, according to the Society for Assisted Reproductive Technology (SART), in 2016 around 1.8% babies born in the U.S were conceived through IVF procedures. However, factors such as high cost of IVF treatment and stringent government regulations are expected to affect market growth. For example, one IVF cycle costs around $12,000 to $15,000 excluding cost of medicines.
Increase in developments in fertility clinics and novel IVF technologies are expected to offer lucrative growth opportunities for IVF service providers in the future. Moreover, rise in number of multiple pregnancy problem cases in the U.S. increase the employment of IVF procedures, which is expected to propel market growth in the near future
The U.S IVF services market is segmented on the basis of cycle type and end user. By cycle type, it is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. According to end user, the market is classified as fertility clinics, hospitals, surgical centers, and clinical research institutes.
The U.S IVF services market is segmented on the basis of cycle type, end user, and country. By cycle type, it is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. On the basis of end user, it is classified as fertility clinics, hospitals, surgical centers, and clinical research institutes.
KEY BENEFITS FOR STAKEHOLDERS
KEY MARKET SEGMENTS
By Cycle Type
By End User
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Delayed pregnancies; aging of women population, which lowers conception rates; and introduction of new & advanced products of IVF treatments enhance market growth. IVF procedures are associated with high success rate, thus fueling market growth. For instance, according to the Society for Assisted Reproductive Technology (SART), in 2016 around 1.8% babies born in the U.S were conceived through IVF procedures. However, factors such as high cost of IVF treatment and stringent government regulations are expected to affect market growth. For example, one IVF cycle costs around $12,000 to $15,000 excluding cost of medicines.
Increase in developments in fertility clinics and novel IVF technologies are expected to offer lucrative growth opportunities for IVF service providers in the future. Moreover, rise in number of multiple pregnancy problem cases in the U.S. increase the employment of IVF procedures, which is expected to propel market growth in the near future
The U.S IVF services market is segmented on the basis of cycle type and end user. By cycle type, it is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. According to end user, the market is classified as fertility clinics, hospitals, surgical centers, and clinical research institutes.
The U.S IVF services market is segmented on the basis of cycle type, end user, and country. By cycle type, it is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. On the basis of end user, it is classified as fertility clinics, hospitals, surgical centers, and clinical research institutes.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the U.S IVF services market.
- In depth quantitative analysis of the current market trends and estimations from 2019 to 2027.
- The IVF services market is analyzed on the basis of cycle type and end user.
- Extensive analysis of the market is conducted by monitoring top competitors within the market framework.
- Key players are profiled to understand the competitive outlook of the U.S market.
KEY MARKET SEGMENTS
By Cycle Type
- Fresh IVF Cycles (Non-Donor)
- Thawed IVF Cycles (Non-Donor)
- Donor Egg IVF Cycles
By End User
- Fertility Clinics
- Hospitals
- Surgical centers
- Clinical research institutes
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- Boston IVF
- Conceptions Reproductive Associates
- Cardone Reproductive Medicine & Infertility
- Fertility Center of San Antonio
- Fertility and Gynecology Center Monterey Bay IVF
- Houston Fertility Center
- New hope fertility center
- Reproductive Medicine Associates of New Jersey
- Servy Massey Fertility Institute
- Sher Institute for Reproductive Medicine (SIRM)
Table of Contents
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
Chapter 4: U. S Ivf Services Market, by End-user
Chapter 5: U. S Ivf Services Market, by Cycle Type
Chapter 6: Company Profiles
Companies Mentioned
- Boston IVF
- Fertility and Gynecology Center Monterey Bay IVF
- Conceptions Reproductive Associates
- Servy Massey Fertility Institute
- Sher Institute for Reproductive Medicine (SIRM)
- Cardone Reproductive Medicine & Infertility
- Fertility Center of San Antonio
- Houston Fertility Center
- New hope fertility center
- Reproductive Medicine Associates of New Jersey
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
